Table 3.
Variable | VTE status |
P value | |
---|---|---|---|
VTEneg n = 29 |
VTEpos n = 12 |
||
BVAS | 12 (8, 13) | 13.5 (7.5, 19.5) | 0.3 |
Anti-Plg (%Pos Co) | 17 (13.8, 23.6) | 21.3 (13.1, 28.9) | 0.5 |
D-dimer (ng/ml) | 208 (149, 811) | 677 (245, 2263) | 0.04 |
hs-CRP (mg/l) | 8.2 (4, 16) | 16 (7.3, 16) [n = 11] | 0.1 |
IL-6 (pg/ml) | 2.6 (1.6, 4) [n = 28] | 4.8 (2.5, 11) | 0.06 |
MPTFa (%Pos Co) | 0 (0, 1.4) [n = 21] | 14 (4.3, 36.6) | <0.0001 |
%Pos Co, % positive control; BVAS, Birmingham Vasculitis Activity Score; anti-Plg, anti-plasminogen; hs-CRP, high-sensitivity C-reactive protein; IL-6, interleukin 6; MPTFa, microparticle tissue factor activity; VTE, venous thromboembolism.
Data are presented as median (interquartile range) of highest values measured (peak values). P values were calculated using a Wilcoxon 2-sample test. Variables with missing values are noted as [different n].